Design, Synthesis and Microbiological Evaluation of Novel Compounds as Potential Staphylococcus aureus Phenylalanine tRNA Synthetase Inhibitors

被引：3

作者：

Elbaramawi, Samar S. ^{[1
,2
]}

Hughes, Casey ^{[3
]}

Richards, Jennifer ^{[4
]}

Gupta, Arya ^{[5
]}

Ibrahim, Samy M. ^{[2
]}

Lashine, El-Sayed M. ^{[2
]}

El-Sadek, Mohamed E. ^{[2
]}

O'Neill, Alex J. ^{[5
]}

Wootton, Mandy ^{[4
]}

Bullard, James M. ^{[3
]}

Simons, Claire ^{[1
]}

机构：

[1] Cardiff Univ, Sch Pharm & Pharmaceut Sci, King Edward VII Ave, Cardiff CF10 3NB, S Glam, Wales

[2] Zagazig Univ, Fac Pharm, Dept Med Chem, Zagazig 44519, Egypt

[3] Univ Texas Rio Grande Valley, Dept Chem, 1201 W Univ Dr, Edinburg, TX 78541 USA

[4] Univ Hosp Wales, Specialist Antimicrobial Chemotherapy Unit, Heath Pk, Cardiff CF14 4XW, S Glam, Wales

[5] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Garstang Bldg, Leeds LS2 9JT, W Yorkshire, England

来源：

EGYPTIAN JOURNAL OF CHEMISTRY | 2018年 / 61卷

基金：

美国国家卫生研究院;

关键词：

Staphylococcus aureus; Phenylalanine tRNA synthetase; Drug design; Benzimiduzole; Indole; Adenine;

D O I：

10.21608/EJCHEM.2018.4070.1357

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

AS THE RESISTANCE of Staphylococcus aureus to antibiotics represents a major threat to global health, anti-infectives with novel mechanisms must be developed. Novel compounds were generated as potential phenylalanine tRNA synthetase (PheRS) inhibitors based on the published homology model of S. aureus PheRS to aid the design process using Molecular Operating Environment (MOE) software. PheRS was selected as it is structurally unique enzyme among the aminoacyl-tRNA synthetases (aaRS), it is considerably different from human cytosolic and human mitochondrial aaRS and it is essential and conserved across bacterial species. The designed compounds were synthesized according to different clear schemes. The compounds were confirmed by H-1 NMR, C-13 NMR, HRMS and/or microanalysis, and they were microbiologically evaluated.

引用

页码：9 / 25

页数：17

共 50 条

[21] Design, synthesis, and evaluation of 1,4-benzothiazine-3-one containing bisamide derivatives as dual inhibitors of Staphylococcus aureus with plausible application in a urinary catheter
Naithani, Kaushal
Das, Arka
Ushare, Mamta
Nath, Subham
Biswas, Rashmita
Kundu, Anirban
Ahmed, Kazi Tawsif
Mohan, Utpal
Bhowmik, Subhendu
FRONTIERS IN CHEMISTRY, 2024, 12
[22] The development of three ruthenium-based antimicrobial metallodrugs: Design, synthesis, and activity evaluation against Staphylococcus aureus
Wang, Liqiang
Huang, Bin
Duan, Xuemin
Jiang, Guijuan
Xiong, Yanshi
Zhong, Shengfei
Wang, Jintao
Liao, Xiangwen
JOURNAL OF CHEMICAL RESEARCH, 2021, 45 (11-12) : 1059 - 1067
[23] Design and Biological Evaluation of Furan/Pyrrole/Thiophene-2-carboxamide Derivatives as Efficient DNA GyraseB Inhibitors of Staphylococcus aureus
Janupally, Renuka
Medepi, Bhramam
Devi, Parthiban Brindha
Suryadevara, Priyanka
Jeankumar, Variam Ullas
Kulkarni, Pushkar
Yogeeswari, Perumal
Sriram, Dharmarajan
CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 918 - 925
[24] Novel Compounds Based on Chalcone- and Pyrazoline-DIM Hybrids as Inhibitors of S taphylococcus aureus, Synthesis, DFT Studies, Biological Evaluation and Docking Studies
Alejandro Ibarra-Hernandez, Javier
Gomez-Balderas, Rodolfo
Nivon-Ramirez, Didier
Guadalupe Garcia-Estrada, Jose
Alberto Mendoza-Jimenez, David
Martinez-Zaldivar, Alejandro
Alejandro Cruz-Sanchez, Tonatiuh
Tovar-Betancourt, Nelly
Alfredo Luna-Mora, Ricardo
Guillermo Penieres-Carrillo, Jose
JOURNAL OF MOLECULAR STRUCTURE, 2022, 1249
[25] Design, Synthesis, Activity Evaluation and Molecular Docking Study of Novel Janus kinase Inhibitors
Du, Wenjun
Zhang, Fuli
Yan, Pei
Lai, Qingfu
Li, Junjian
Zhu, Daqian
Ye, Lianbao
CHEMISTRYSELECT, 2021, 6 (17): : 4212 - 4216
[26] Design, synthesis and biological evaluation of novel molecules as potent PARP-1 inhibitors
Shen, Hui
Ge, Yiran
Wang, Junwei
Li, Hui
Xu, Yungen
Zhu, Qihua
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 47
[27] Design, Synthesis and Biological Evaluation of Uracil Derivatives as Novel VEGFR-2 Inhibitors
Liang, Jingwei
Li, Xinyang
Yang, Su
He, Xin
Wang, Mingyang
Meng, Fanhao
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (06) : 734 - 740
[28] Design, Synthesis and Biological Evaluation of Novel Imidazolone Derivatives as Dipeptidyl Peptidase 4 Inhibitors
Liu, Yang
Jiang, Chaoyi
Wu, Haoshu
Wu, Peng
Si, Meimei
Hu, Yongzhou
Liu, Tao
MEDICINAL CHEMISTRY, 2013, 9 (07) : 938 - 946
[29] Novel indolotacrine hybrids as acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and molecular docking studies
Babaee, Saeed
Zolfigol, Mohammad Ali
Chehardoli, Gholamabbas
Faramarzi, Mohammad Ali
Mojtabavi, Somayeh
Akbarzadeh, Tahmineh
Hariri, Roshanak
Rastegari, Arezoo
Homayouni Moghadam, Farshad
Mahdavi, Mohammad
Najafi, Zahra
JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2023, 20 (05) : 1049 - 1060
[30] Novel indolotacrine hybrids as acetylcholinesterase inhibitors: design, synthesis, biological evaluation, and molecular docking studies
Saeed Babaee
Mohammad Ali Zolfigol
Gholamabbas Chehardoli
Mohammad Ali Faramarzi
Somayeh Mojtabavi
Tahmineh Akbarzadeh
Roshanak Hariri
Arezoo Rastegari
Farshad Homayouni Moghadam
Mohammad Mahdavi
Zahra Najafi
Journal of the Iranian Chemical Society, 2023, 20 : 1049 - 1060

← 1 2 3 4 5 →